Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pinter

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
Collegium Antropologicum|July 26, 2002
Metabolic syndrome X--high risk factor for acute myocardial infarction and its complicationsD Kranjcec, A Pinter, T Birtić, et al.
The British Journal of Dermatology|September 17, 2020
Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatmentA Leutz, A Pinter, D Thaçi, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 1991
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virusM Girard, M P Kieny, A Pinter, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 6, 2023
Speed of clinical improvement in the real-world setting from patient-reported Psoriasis Symptoms and Signs Diary: Secondary outcomes from the Psoriasis Study of Health Outcomes through 12 weeksA Reich, A Pinter, J-T Maul, et al.
Journal of Virology|April 1, 1995
Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: role of glycosylation in the correct folding of the V1/V2 domainZ Wu, S C Kayman, W Honnen, et al.
British Journal of Cancer|January 25, 2007
In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathwayD Pils, A Pinter, J Reibenwein, et al.
Veterinary Research Communications|March 3, 2004
Occurrence of anti-Toxoplasma gondii antibodies in dogs in the urban area of Monte Negro, Rondônia, BrazilW A Cañón-Franco, D P Bergamaschi, M B Labruna, et al.
AIDS Research and Human Retroviruses|October 1, 1993
Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the central African RepublicE Murphy, B Korber, M C Georges-Courbot, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1997
Vaccine-specific antibody responses induced by HIV-1 envelope subunit vaccinesS H Pincus, K G Messer, R Cole, et al.
The British Journal of Dermatology|November 10, 2019
Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS)D Thaçi, A Pinter, M Sebastian, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Collegium Antropologicum|July 26, 2002
Metabolic syndrome X--high risk factor for acute myocardial infarction and its complicationsD Kranjcec, A Pinter, T Birtić, et al.
The British Journal of Dermatology|September 17, 2020
Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatmentA Leutz, A Pinter, D Thaçi, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 1991
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virusM Girard, M P Kieny, A Pinter, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 6, 2023
Speed of clinical improvement in the real-world setting from patient-reported Psoriasis Symptoms and Signs Diary: Secondary outcomes from the Psoriasis Study of Health Outcomes through 12 weeksA Reich, A Pinter, J-T Maul, et al.
Journal of Virology|April 1, 1995
Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: role of glycosylation in the correct folding of the V1/V2 domainZ Wu, S C Kayman, W Honnen, et al.
British Journal of Cancer|January 25, 2007
In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathwayD Pils, A Pinter, J Reibenwein, et al.
Veterinary Research Communications|March 3, 2004
Occurrence of anti-Toxoplasma gondii antibodies in dogs in the urban area of Monte Negro, Rondônia, BrazilW A Cañón-Franco, D P Bergamaschi, M B Labruna, et al.
AIDS Research and Human Retroviruses|October 1, 1993
Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the central African RepublicE Murphy, B Korber, M C Georges-Courbot, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1997
Vaccine-specific antibody responses induced by HIV-1 envelope subunit vaccinesS H Pincus, K G Messer, R Cole, et al.
The British Journal of Dermatology|November 10, 2019
Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS)D Thaçi, A Pinter, M Sebastian, et al.
Pageof 13